Skip to main content

Table 17 The cost-effectiveness analysis in the 12-month intervention period (the incidence of diabetes)

From: The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design

Group C (yuan) E (%) C/E ΔC/ΔE
The treatment group 22967057.6 16.5 1391942.9 −204989.1
The control group 20425193.3 28.9 706754.1